Facilitated By

San Antonio Medical Foundation

Compound testing for Therapeutics Development against Coronavirus (COVID-19)

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Carrion, Ricardo
Funded by
Southwest Research Institute
Research Start Date
Status
Inactive

The primary objective of this project is to identify drug compounds that may inhibit SARS-CoV-2 replication in an in vitro tissue culture assay. Vero E6 cells will be used to evaluate the effectiveness of the test articles to inhibit SARS-CoV-2 replication.

Collaborative Project
Drug Discovery
Infectious Disease